Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

laboratorios hipra, s.a. - mycoplasma hyopneumoniae, strain 7304 (nexhyon), expressing the capsid protein of porcine circovirus type 2a, inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - Χοίροι - for the active immunisation of pigs:to reduce lung lesions associated with porcine enzootic pneumonia caused by mycoplasma hyopneumoniae. also, to reduce the incidence of these lesions (as observed in field studies). to reduce viraemia, virus load in lungs and lymphoid tissues and the duration of the viraemic period associated with diseases caused by porcine circovirus type 2 (pcv2). efficacy against pcv2 genotypes a, b and d has been demonstrated in field studies. to reduce culling rate and the loss of daily weight gain caused by mycoplasma hyopneumoniae and/or pcv2 related diseases (as observed at 6 months of age in field studies). mycoplasma hyopneumoniae: onset of immunity: 3 weeks after vaccinationduration of immunity: 23 weeks after vaccinationporcine circovirus type 2:onset of immunity: 2 weeks after vaccinationduration of immunity: 22 weeks after vaccinationin addition, a reduction in nasal and faecal shedding and the duration of nasal excretion of pcv2 was demonstrated in animals challenged at 4 weeks and at 22 weeks after vaccination.

Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

intervet international bv (0000000669) wim de korvestraat 35, boxmeer, nl-5831 - inactivated porcine parvovirus, strain 014; inactivated (lysed) erysipelothrix rhusiopathiae, strain m2, serotype 2 - suspension for injection - inactivated porcine parvovirus, strain 014 (8900000029) 360.4mg; inactivated (lysed) erysipelothrix rhusiopathiae, strain m2, serotype 2 (8900000030) 400mg - porcine parvovirus + erysipelothrix

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

boehringer ingelheim vetmedica gmbh, ingelheim am rhein, germany (0000003115) -,55216,ingelheim/rhein,de - porcine circovirus type 2 orf2 protein - ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - - - porcine circovirus type 2 orf2 protein 0,00 inj.susp - - porcine circovirus - Χοίροι - Χρόνοι αναμονής: Χοίροι 0 Ημέρες Κρέας και εδώδιμοι ιστοί

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

intervet international bv (boxmer), holland (0000005707) wim de körverstraat 35,5831 an boxmeer,boxmeer,nl - porcine circovirus type 2 orf2 subunit antigen; mycoplasma hyopneumoniae j.strain, ΜΟΝΩΜΑ b-3745 - ΕΝΕΣΙΜΟ ΓΑΛΑΚΤΩΜΑ - porcine circovirus type 2 orf2 subunit antigen 2,828 em.inj 0; mycoplasma hyopneumoniae j.strain, ΜΟΝΩΜΑ b-3745 2,69 em.inj 0 - porcine circovirus - Παχυνόμενοι χοίροι - Χρόνοι αναμονής: Παχυνόμενοι χοίροι 0 Ημέρες Κρέας και εδώδιμοι ιστοί

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

intervet international bv (boxmer), holland (0000005707) wim de körverstraat 35,5831 an boxmeer,boxmeer,nl - porcine circovirus type 2 orf2 subunit antigen - ΕΝΕΣΙΜΟ ΓΑΛΑΚΤΩΜΑ - >=4,5log2 eu - porcine circovirus type 2 orf2 subunit antigen 0,00 em.inj >=4,5log2 eu - porcine circovirus - Χοίροι - Χρόνοι αναμονής: Χοίροι 0 Ημέρες Κρέας και εδώδιμοι ιστοί

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

boehringer ingelheim vetmedica gmbh, ingelheim am rhein, germany (0000003115) -,55216,ingelheim/rhein,de - porcine parvovirus strain 27a vp2 subunit antigen - ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - >=1rp/2ml - porcine parvovirus strain 27a vp2 subunit antigen 1,00 inj.susp >=1rp/2ml - porcine parvovirus - Χοίροι - Χρόνοι αναμονής: Χοίροι 0 Ημέρες Κρέας και εδώδιμοι ιστοί